Agilent Technologies ROE 2010-2024 | A
Current and historical return on equity (ROE) values for Agilent Technologies (A) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Agilent Technologies ROE - Return on Equity Historical Data |
Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
2024-07-31 |
$1.41B |
$5.90B |
23.40% |
2024-04-30 |
$1.24B |
$6.21B |
20.87% |
2024-01-31 |
$1.24B |
$6.19B |
21.15% |
2023-10-31 |
$1.24B |
$5.85B |
21.76% |
2023-07-31 |
$1.13B |
$5.56B |
20.37% |
2023-04-30 |
$1.35B |
$5.78B |
24.80% |
2023-01-31 |
$1.32B |
$5.61B |
25.05% |
2022-10-31 |
$1.25B |
$5.31B |
24.26% |
2022-07-31 |
$1.33B |
$5.09B |
25.59% |
2022-04-30 |
$1.26B |
$5.12B |
24.51% |
2022-01-31 |
$1.21B |
$5.15B |
23.75% |
2021-10-31 |
$1.21B |
$5.39B |
24.26% |
2021-07-31 |
$0.99B |
$4.95B |
20.38% |
2021-04-30 |
$0.93B |
$4.81B |
19.01% |
2021-01-31 |
$0.81B |
$4.80B |
16.68% |
2020-10-31 |
$0.72B |
$4.87B |
14.77% |
2020-07-31 |
$0.69B |
$4.98B |
14.29% |
2020-04-30 |
$0.68B |
$4.77B |
14.30% |
2020-01-31 |
$0.76B |
$4.85B |
15.70% |
2019-10-31 |
$1.07B |
$4.75B |
21.79% |
2019-07-31 |
$1.07B |
$4.75B |
22.01% |
2019-04-30 |
$1.12B |
$5.13B |
23.15% |
2019-01-31 |
$1.14B |
$5.04B |
24.27% |
2018-10-31 |
$0.32B |
$4.57B |
6.91% |
2018-07-31 |
$0.30B |
$4.57B |
6.43% |
2018-04-30 |
$0.24B |
$4.62B |
5.10% |
2018-01-31 |
$0.20B |
$4.53B |
4.27% |
2017-10-31 |
$0.68B |
$4.84B |
15.10% |
2017-07-31 |
$0.63B |
$4.61B |
14.44% |
2017-04-30 |
$0.58B |
$4.38B |
13.48% |
2017-01-31 |
$0.51B |
$4.30B |
11.94% |
2016-10-31 |
$0.46B |
$4.25B |
11.00% |
2016-07-31 |
$0.48B |
$4.35B |
11.38% |
2016-04-30 |
$0.46B |
$4.17B |
11.23% |
2016-01-31 |
$0.46B |
$4.05B |
11.14% |
2015-10-31 |
$0.40B |
$4.17B |
9.62% |
2015-07-31 |
$0.28B |
$4.11B |
6.22% |
2015-04-30 |
$0.31B |
$4.16B |
6.47% |
2015-01-31 |
$0.37B |
$4.24B |
7.01% |
2014-10-31 |
$0.50B |
$5.30B |
9.03% |
2014-07-31 |
$0.69B |
$5.64B |
12.58% |
2014-04-30 |
$0.71B |
$5.63B |
13.48% |
2014-01-31 |
$0.74B |
$5.45B |
14.21% |
2013-10-31 |
$0.72B |
$5.29B |
13.96% |
2013-07-31 |
$0.94B |
$4.79B |
18.18% |
2013-04-30 |
$1.01B |
$5.31B |
19.56% |
2013-01-31 |
$1.10B |
$5.35B |
21.89% |
2012-10-31 |
$1.15B |
$5.19B |
23.92% |
2012-07-31 |
$1.02B |
$4.87B |
22.09% |
2012-04-30 |
$1.10B |
$4.73B |
24.89% |
2012-01-31 |
$1.05B |
$4.50B |
24.72% |
2011-10-31 |
$1.01B |
$4.32B |
25.59% |
2011-07-31 |
$1.02B |
$4.20B |
27.55% |
2011-04-30 |
$0.89B |
$3.96B |
26.67% |
2011-01-31 |
$0.80B |
$3.34B |
26.56% |
2010-10-31 |
$0.68B |
$3.24B |
24.26% |
2010-07-31 |
$0.42B |
$2.81B |
15.80% |
2010-04-30 |
$0.19B |
$2.63B |
7.54% |
2010-01-31 |
$-0.02B |
$2.60B |
-0.64% |
2009-10-31 |
$-0.03B |
$2.51B |
-1.24% |
Sector |
Industry |
Market Cap |
Revenue |
Computer and Technology |
Electrical Test Equipment |
$38.462B |
$6.833B |
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
|